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Abstract
A membrane proteinase from Pseudomonas aeruginosa, called insulin-cleaving membrane proteinase (ICMP), was
located in the outer membrane leaflet of the cell envelope. The enzyme is expressed early in the logarithmic phase
parallel to the bacterial growth during growth on peptide rich media. It is located with its active center facing to the
outermost side of the cell, because its whole activity could be measured in intact cells. The very labile membrane
proteinase was solubilized by non-ionic detergents (Nonidet P-40, Triton X-100) and purified in its amphiphilic form to
apparent homogeneity in SDS-PAGE by copper chelate chromatography and two subsequent chromatographic steps on
Red-Sepharose CL-4B (yield 58.3%, purification factor 776.3). It consisted of a single polypeptide chain with a molecular
mass of 44.6 kDa, determined by mass spectrometry. ICMP was characterized to be a metalloprotease with pH-optimum
in the neutral range. The ICMP readily hydrolyzed Glu13-Ala14 and Tyr16-Leu17 bonds in the insulin B-chain. Phe25-
Tyr26 and His10-Leu11 were secondary cleavage sites suggesting a primary specificity of the enzyme for hydrophobic or
aromatic residues at PP1-position. The ICMP differed from elastase, alkaline protease and LasA in its cleavage
specificity, inhibition behavior and was immunologically diverse from elastase. The amino acid sequence of internal
peptides showed no homologies with the known proteinases. This outer membrane proteinase was capable of specific
cleavage of K and L fibrinogen chains. Among the p-nitroanilide substrates tested, substrates of plasminogen activator,
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complement convertase and kallikrein with arginine residues in the P1-subsite were the substrates best accepted, but they
were only cleaved at a very low rate. ß 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
Pseudomonas aeruginosa is an opportunistic patho-
gen causing acute infections in individuals with com-
promised defense mechanisms, such as burnt or neu-
tropenic patients [1]. Another important aspect in P.
aeruginosa-caused pathogenesis is its characteristic
association with the respiratory tract in patients
with cystic ¢brosis (CF) [2,3].
A number of factors appear to be involved in the
ability of Pseudomonas to cause invasive disease.
While surface structures, including pili and the poly-
saccharide capsule or glycocalyx, appear to mediate
the initial attachment of P. aeruginosa to its prospec-
tive host [4,5], thus permitting colonization, its ex-
tracellular enzymes or toxins break down physical
barriers and impair host defenses. Most clinical P.
aeruginosa isolates produce several extracellular pro-
teases. Two of the best characterized, elastase and
alkaline protease, belong to the main extracellular
virulence factors of Pseudomonas aeruginosa besides
hemolysins, exoenzyme S and exotoxin A [6].
Because of the important role of P. aeruginosa as a
pathogen and the emerging importance of microbial
membrane proteinases in the penetration of the ex-
tracellular matrix, in£ammation and sepsis [7^9], we
investigated the cell envelope fractions with regard to
novel proteolytic activities with various protease sub-
strates. Using the sensitive 125I-insulin assay, a new
proteolytic activity located in the cell envelope was
detected. After solubilization with non-ionic deter-
gents, the main portion of the solubilized insulin-
cleaving activity was concentrated in the detergent
phase as a result of phase separation procedures
[10], whereby the amphipathic nature of this cell en-
velope proteinase could be established.
The insulin-cleaving membrane protease (ICMP)
of Pseudomonas aeruginosa was puri¢ed and charac-
terized in its detergent form. The description of its
properties in comparison to the known proteases of
Pseudomonads, its unusual behavior during solubili-
zation and puri¢cation, and its potential role in path-
ogenicity are the subjects of the following article.
2. Materials and methods
2.1. Chemicals
The peptidase and protease substrates were ob-
tained from Serva (Heidelberg, Germany) or Calbio-
chem (Bad Soden, Germany). Calibration proteins
for the gel ¢ltration, octylthioglucoside, sulfobetain
SB-12, Brij-35, Triton X-100, and lysozyme from
chicken egg were purchased from Serva (Heidelberg,
Germany). RNase, DNaseI from bovine pancreas
and the protease inhibitors bacitracin, gramicidin,
DEPC, pCMB, dithizon, o-phenanthroline, 2,2P-pyr-
idine, trasylol, zincov, captopril, E-64, phosphorami-
don, thiorphan, Pefabloc, PMSF, elastatinal, leupep-
tin, antipain, chymostatin, TPCK, and TLCK were
manufactured by Boehringer (Mannheim, Germany).
Red Sepharose CL-4B, and Sephadex G-150 were
obtained from Pharmacia (Freiburg, Germany). Ace-
tonitrile (gradient grade), Fractogel Chelate, and cal-
ibration proteins VIII for the SDS-PAGE were ob-
tained from Merck (Darmstadt, Germany). Sodium
lauroylsarkosinate, sodium deoxycholate, Nonidet P-
40, K-casein, L-casein and U-casein, oxidized bovine
insulin A-chain and B-chain, disulfonate, were pur-
chased from Sigma (Deisenhofen, Germany). Amber-
lite XAD-16 absorbens was obtained from Supelco
(Deisenhofen, Germany) and A⁄gel 15 from Bio-
Rad (Munich, Germany. Elastase from P. aeruginosa
was delivered by Elastin Products (Owensville, MO).
Aminocapronic-O-Divicell was a generous gift from
Dr. Peters (Institute of Physiological Chemistry,
Medical Faculty, University, Halle, Germany).
2.2. Cultivation conditions
Pseudomonas aeruginosa strain PAO1 was ob-
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tained from the strain collection of the Institute of
Biochemistry (University, Leipzig, Germany). Bacte-
ria were cultivated on a complex medium consisting
of 10 g yeast extract (Difco, Detroit, MI), 5 g
(NH4)2PO4, 2.2 g KH2PO4, 10.1 g Na2HPO4U12
H2O, 0.2 g MgSO4U7 H2O and 0.2 g CaCl2 per liter
medium (pH 7.0) in a fermentor (Biostat S, Braun,
Melsungen, Germany) at 37‡C, pH regulated to 7.0,
a stirring rate of 120 rpm and an aeration rate of 6 l
min31 until the end of the exponential growth.
Freshly harvested bacterial cells were washed with
an excess of sodium chloride solution (5 g l31) and
suspended in bu¡er A (Tris-HCl bu¡er, 0.05 M, pH
7.5) in a cell concentration of approximately 100 mg
dry weight ml31. Cells were disintegrated by stirring
with an equal volume of glass beads and the cell
envelopes were separated by ultracentrifugation (1 h,
90 000Ug) from soluble components. Sediments were
resuspended in bu¡er A, washed under the same con-
ditions and stored at 320‡C.
For the determination of the ICMP synthesis dur-
ing growth, samples from the fermentor were taken
at 1-h intervals and the cells were disintegrated by
ultrasonic treatment (Branson soni¢er B-12). The cell
components were separated by ultracentrifugation
(conditions as above).
2.3. Sucrose density centrifugation
For sucrose density centrifugation, 0.5 ml washed
cell envelopes were mixed with 5 ml bu¡er A. RNase
and DNase (1 mg each) and 5 mg of lysozyme were
added from a stock solution, and the mixture was
shaken for 1 h at room temperature. After separation
of the cell envelopes from the supernatant by ultra-
centrifugation, the sediment was resuspended in 0.5
ml bu¡er A and layered onto the top of a discontin-
uous sucrose gradient (11.5 ml) generated from var-
ious sucrose concentrations in a range from 10 to
60% (w/w) dissolved in bu¡er A. The gradients
were centrifuged for 24 h (Swing-out rotor,
96 000Ug, Spinco, Beckman) and fractions of 0.7
ml were collected from the bottom. The protein con-
tent, sucrose density, 2-ketodeoxyoctulonate (KDO)
content, marker enzymes and proteolytic activity
were determined for each fraction. NADH-dehydro-
genase was determined as marker enzyme for the
cytoplasmic membrane by a continuous kinetic assay
[11]. The marker substance for the outer membrane,
KDO, was determined in sucrose-free samples (TCA-
precipitated) by the thiobarbituric acid method [12].
2.4. Determination of the crypticity
Cells of the late logarithmic phase were washed,
resuspended in bu¡er A and divided into halves. One
part was treated with 10 mg lysozyme (egg white),
1% (w/v) Triton X-100, 10 mg RNase and 10 mg
DNase for 1 h at 37‡C to lyze the cells. Proteolytic
activity against 125I-insulin was determined for intact
and for lyzed cells and compared.
2.5. Solubilization
Cell envelopes were homogenized in an equal vol-
ume of detergent and shaken for 1 h at room temper-
ature (180 rpm). Sediment was separated from the
supernatant by centrifugation (1 h, 90 000Ug) and
redissolved in the same detergent bu¡er. Before any
puri¢cation attempts, the detergent content in the
solubilizate (Nonidet P-40, Triton X-100) was always
adjusted to approximately 0.1% (w/v) by adsorption
to Amberlite XAD-16 beads.
2.6. Determination of enzymatic activities
The insulin-cleaving proteinase of P. aeruginosa
was determined in an assay with porcine insulin io-
dinated by chloramine-T with 125I-iodine. The tracer
concentration was adjusted to approximately 1U106
cpm ml31 with bu¡er A, containing 0.1% w/v HSA.
For each enzyme assay, a tracer amount of 2^4U105
cpm was used and cold insulin was added to an assay
concentration of 100 nM. After incubation at 37‡C,
the reaction was stopped by the addition of TCA
(¢nal concentration 10% w/v) and HSA (¢nal con-
centration 2.5% w/v). Aliquots of centrifugation
supernatants were measured in a Q-counter (LB
2104, Berthold, Germany). The proteolytic activity
was calculated as Wg insulin cleaved per hour.
The cleavage of other proteins was determined
after 14C-acetylation of the substrate proteins [13].
Additionally, cleavage of substrate proteins was as-
sessed in SDS-PAGE. Measurement of the elastolytic
activity was adapted from Sachar et al. [14] with
elastin orcein. 3H-elastin labeled by the borohydride
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method [15] was a gift from Mrs. Prof. Dr. Kirschke
(Institute of Physiological Chemistry, Medical Fac-
ulty, University, Halle-Wittenberg, Germany).
The cleavage of synthetic p-nitroanilide substrates
was determined photometrically at 405 nm in a mi-
croplate assay with and without addition of amino-
peptidase M for N-protected substrates consisting of
more than one amino acid [16]. The cleavage of fur-
ylacroleyl substrates was measured at 345 nm [17].
Protein content was determined by the bicincho-
ninic acid (BCA) method according to the manufac-
turer’s instructions (Bio-Rad, Munich, Germany).
2.7. Electrophoresis
The purity of various puri¢cation stages and the
cleavage of substrate proteins was determined by
SDS-polyacrylamide gel electrophoresis in a discon-
tinuous Tris/glycin system using gels of various acryl-
amide concentration (Mini-Protean II cell, Bio-Rad,
Munich, 1 mm thickness) [18]. Gels were stained ei-
ther with Coomassie brilliant blue R-250 or silver
(Bio-Rad, Munich, Germany).
2.8. Puri¢cation
2.8.1. Metal chelate chromatography
Solubilizate was applied onto a Fractogel chelate
column (3.5U10 cm) loaded with copper and equili-
brated with bu¡er I (pH 7.5, 0.02 M, containing
additional 0.1% w/v Triton X-100 and 1 mM imida-
zole). The excess of Triton X-100 (4% w/v) did not
have to be removed before loading for this puri¢ca-
tion step. Nevertheless, the ICMP was strongly
bound to the matrix. The column was eluted with a
gradient (400 ml) of bu¡er II (similar to bu¡er I, but
with 30 mM imidazole). Fractions with insulin-cleav-
ing activity were combined, concentrated on a YM-
10 membrane (Amicon) and dialyzed against an ex-
cess of an imidazole-free Tris-HCl bu¡er (bu¡er A).
2.8.2. I. Red-Sepharose CL-4 chromatography
The pool concentrated and dialyzed was loaded on
a Red-Sepharose CL-4B column (2.5U6 cm) and
eluted with a gradient ranging from 0 to 0.5 M
NaCl in Tris-HCl bu¡er (pH 7.5, 0.05 M with
0.1% Triton X-100). The ICMP was eluted with the
¢rst fractions of the washing step.
2.8.3. II. Red-Sepharose CL-4B chromatography
Active fractions in the through-£ow were concen-
trated, adjusted to 20% ammonium sulfate saturation
and chromatographed on a second Red-Sepharose
column (2.5U6 cm), equilibrated with Tris-HCl bu¡-
er, pH 7.5, 20 mM, containing 20% ammonium sul-
fate saturation. The column was developed with a
gradient ranging from 20 to 0% ammonium sulfate
and simultaneously from 0 to 0.1% w/v Triton X-
100. The ICMP was the only protein not absorbed
to the matrix and was eluted in the ¢rst fractions of
the washing step again. The active fractions were
combined, concentrated and, after the addition of
Triton X-100 to the sample to a ¢nal concentration
of 0.1% (w/v), dialyzed to remove ammonium sulfate
and stored at 320‡C.
2.9. Cleavage speci¢city
ICMP was incubated with insulin A- and B-chain
(1:400 by mass) in ammonium carbonate bu¡er, ad-
justed to pH 7.5, for various time periods (15, 30, 45,
60, 90 min) at 37‡C. The hydrolysis products were
separated and fractionated on a 250U4 mm Li-
ChroSpher 300 RP 18 (5 Wm) column from Merck
(Germany) using a Merck-Hitachi-LiChroGraph sys-
tem with a L-6200 low-gradient pump, a 655-A UV-
detector and an HM-computing integrator and later
identi¢ed by mass spectrometry.
2.10. Mass spectrometry
MALDI mass spectrometry was performed on a
re£ectron-type time-of-£ight (TOF) mass spectrome-
ter (REFLEX, Bruker^Franzen Analytik, Bremen,
Germany). Ions formed by laser desorption at 337
nm (N2-laser) were recorded at an acceleration volt-
age of 28.5 kV in the linear mode. The resulting data
were analyzed using the post-acquisition software
XMASS supplied with the spectrometer.
For the determination of the peptide masses, the
matrix K-cyano-4-hydroxycinnamic acid and nitro-
cellulose were dissolved in acetone to a concentration
of 20 and 5 g l31, respectively. One Wl of the matrix/
nitrocellulose solution was deposited on a stainless-
steel sample stage and 1 Wl of peptide solution was
spotted onto this matrix surface.
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2.11. Determination of internal amino acid sequences
Bound detergent and phospholipids were extracted
with acetone after TCA-precipitation of the puri¢ed
proteinase. The protein was redissolved in 70% w/v
formic acid and desalted by reversed phase HPLC on
a C3-column (125U2 mm, 5 C3 500 PPN, Macherey-
Nagel) at a £ow rate of 0.2 ml min31 and a gradient
ranging from 30 to 60% eluent B (eluent A, 0.09%
TFA in water; eluent B, 0.08% TFA in acetonitrile).
Because the N-terminus was blocked, internal pep-
tides were formed by trypsin cleavage, puri¢ed by
HPLC and sequenced according to the manufactur-
er’s protocol (Protein Sequencer 476A, Perkin-Elmer,
Weiterstadt, Germany).
2.12. Immunological methods
Antibodies were generated in a rabbit by injecting
puri¢ed elastase (40 Wg) with complete Freund adju-
vant. Subsequent injections with incomplete Freund
adjuvant were done subcutaneously in the neck re-
gion 4 weeks later and were repeated, when neces-
sary. The titer of the elastase antiserum was deter-
mined by Western blotting with peroxidase-labeled
goat anti-rabbit IgG and nitroblue-tetrazolium salt
following the method described by Towbin et al. [19].
Immunodouble di¡usion was carried out corre-
sponding to a standard procedure [20] with 1% w/v
agarose to test the immunological similarity of elas-
tase and ICMP.
3. Results
3.1. Expression and localization in the cell
The ICMP was formed early in the logarithmic
phase parallel to the growth. The synthesis of the
ICMP in the particulate fractions followed a trend
similar to the soluble compartment until the station-
ary phase was reached. Later the cytosolic activity
increased further in contrast to the cell envelope-
bound activity (Fig. 1). Medium activity against in-
sulin was expressed much later, beginning at ¢rst
during transition to the stationary phase.
The particulate fraction contained on average ap-
proximately 51 þ 6% of the entire cell-bound activity
(results of ¢ve di¡erent cultivations). After treatment
of the washed cell envelopes with lysozyme and nu-
cleases, as mentioned above, this portion of activity
remained bound to the particulate fraction; therefore
the insulin-cleaving activity of the cell envelopes is a
real membrane enzyme and not attached to the cell
wall and also not associated with ribosomes or nu-
cleoids. Because ICMP is a zinc metalloprotease,
which is di⁄cult to reactivate and very sensitive to
denaturating in£uences [21], it was not possible to
select a method for generating intact spheroblasts
by lysozyme/EDTA treatment from the outerside of
the cell.
Two de¢ned protein peaks were detected in the
sucrose gradients, one at a higher density
(1.21 þ 0.02 g cm33) with the main part of KDO
(on average 92% of the whole KDO content in the
gradient) as the marker substance of the lipopolysac-
charides from the outer membrane and the other at
1.16 þ 0.02 g cm33, characterized by the NADH-de-
hydrogenase as the marker enzyme of the cytoplas-
mic membrane. These membrane densities corre-
spond well to the values determined by Nikaido for
P. aeruginosa outer and cytoplasmic membranes [22].
The insulin-cleaving activity was unequivocally lo-
cated in the outer membrane fractions. Only low
amounts of the ICMP were found in the cytoplasmic
membranes (Fig. 2).
Fig. 1. Synthesis of insulin-cleaving proteinase during growth of
P. aeruginosa on a complex medium containing 1% yeast ex-
tract. b, optical density (OD); F, insulin-cleavage in the me-
dium; 8, insulin-cleavage of the cytosol ; +, insulin-cleavage of
the cell envelopes (CE).
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In accordance with these results, the crypticity of
P. aeruginosa cells for 125I-insulin was very low.
Freshly harvested and washed, intact bacterial cells
were capable of cleaving iodinated insulin o¡ered
externally at a higher rate than lyzed cells (average
of 85 þ 3% in relation to intact cells). Presumably, the
lower values for the lyzed cells were a result of com-
petitive inhibition by intracellular proteins and poly-
peptides in the homogenate. Polypeptides as insulin
cannot pass the water ¢lled porin channels in the
outer membrane, because the exclusion limit for hy-
drophilic compounds for the P. aeruginosa outer
membrane was determined to be with 600^700 Da,
even lower than for other Gram-negative bacteria
[23]. Therefore, the ICMP seems to be located at
the outermost side of the outer membrane, freely
accessible to its substrates.
3.2. Solubilization
Solubilization of the ICMP was tested using ionic,
zwitterionic and non-ionic detergents (Fig. 3). The
most e¡ective detergent was the polyoxyethylene de-
tergent Nonidet P-40, comparable in its e⁄ciency
with Triton X-100, a detergent with a similar struc-
ture, but bearing an octyl residue instead of an ethyl
residue on the hydrophobic phenol part of the mol-
ecule. The e¡ect of various detergents on the enzy-
matic activity and their solubilization e¡ect are
shown in Fig. 3. Although all detergents were tested
over a wide range of concentrations, only the con-
centration of 0.5% (w/v) is represented in Fig. 3.
Additionally, the highest concentration for Nonidet
P-40, which was used further for the complete solu-
bilization of the ICMP, is shown. Some detergents
were inhibitory on the enzymatic activity (for exam-
ple, octylthioglucoside, sodium cholate, sulfobetain
SB-12). Only at high detergent concentrations, the
membrane enzyme could be solubilized almost com-
pletely using Nonidet P-40 or Triton X-100, which is
similar in e⁄ciency. The high detergent excess was
adjusted to a concentration of 0.1% (w/v) Nonidet P-
40 or to an equivalent of Triton X-100 by adsorption
of the detergent to Amberlite XAD-16 for testing
various puri¢cation methods.
3.3. Puri¢cation
The ICMP was irreversibly inactivated by NaCl,
organic solvents (Table 1) and alkaline and acid pH.
Due to this special sensitivity of the enzyme, the
spectrum of applicable puri¢cation procedures was
strongly restricted. Various kinds of ion-exchange
chromatography (DEAE-Sephacel, TMAE-Fracto-
gel, CM-Sepharose) resulted in very low yields and
sometimes complete inactivation. Some chromato-
graphic matrices of the hydroxylapatite type, usually
employed for membrane proteins, were also ine⁄-
Fig. 3. Solubilization of ICMP by various detergents (A, 0.5%
w/v sodium cholate; B, 0.5% w/v sulfobetain SB-12; C, 0.5%
sodium lauroylsarkosinate; D, 0.5% w/v octylthioglucoside; E,
0.5% Brij-35; F, 0.5% w/v Nonidet P-40; G, 4% w/v Nonidet
P-40).
Fig. 2. Sucrose gradient for cell envelopes from P. aeruginosa
after lysozyme and nuclease treatment. a, protein content; S,
NADH dehydrogenase; F, insulin cleavage; U, KDO content.
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cient, because the resulting yields were low (below
10% of the start activity) and the residual activity
became unstable. The high-resolving puri¢cation
methods chromatofocusing and preparative isoelec-
tric focusing were accompanied by the same negative
e¡ects, because lowering pH to the isoelectric point
of 5.3 entailed a partial, irreversible inactivation,
progressive with the exposition time.
Typical kinds of a⁄nity chromatography for sim-
ilar metalloproteinases, like bacitracin a⁄nity chro-
matography [24] and insulin a⁄nity chromatography
[25] were not e¡ective, even though ligands were
coupled with good yields to various matrices with
and without spacer molecules (for example BrCN-
activated Sepharose 4-B, A⁄gel 15, Fractogel
EMD epoxy, aminocapronic-O-Divicell). The ICMP
was not bound to the insulin and the bacitracin af-
¢nity matrices, even though other proteases, like
thermitase, tested with the same bacitracin gels
were bound well. This behavior can be interpreted
as special three-dimensional demands of the ICMP
for substrate and inhibitor binding, not ful¢lled by
ligands attached to a matrix.
A combination of copper chelate chromatography
with stain-ligand chromatography was the ¢rst e¡ec-
tive procedure to purify the enzyme with a good
yield (Table 2) to its apparent electrophoretic homo-
geneity (Fig. 4). Despite the high Triton X-100 con-
centration in the solubilizate, the ICMP was bound
to the copper chelate matrix without previously de-
creasing the detergent concentration. The decrease in
the speci¢c activity for this step was not only caused
by copper inhibition, but was also the result of the
diminished detergent concentration, because the acti-
vation at high Triton X-100 concentrations (approx-
imately a 2.5-fold activation during the solubilization
procedure Table 2) was neutralized. In the following
puri¢cation steps on Red-Sepharose CL-4B, the con-
taminating proteins were bound to the matrix under
Table 1
In£uence of di¡erent inhibitors, organic solvents, and thiol
agents on the puri¢ed ICMP
Compound Concentration Residual activity
EDTA 1 mM 0%
o-Phenanthroline 1 mM 6%
PMSF 1 mM 109%
Iodacetamide 1 mM 97%
pCMB 1 mM 63%
E-64 0.1 mM 82%
DEPC 1 mM 0.3%
Elastatinal 0.1 mM 104%
Trasylol 2000 KIU 68%
Bacitracin 1 mg/ml 15%
N-Cbz-Phe-CK 1 mM 102%
N-Cbz-Phe-Leu 0.1 mM 82.9%
Phosphoramidon 0.1 mM 73%
Zincov 0.1 mM 63.6%
Captopril 0.1 mM 97.6%
Thiorphan 0.1 mM 90%
NaCl 0.5 M 45%
Imidazole 50 mM 53%
Ethanol 10% v/v 6%
Propan-2-ol 10% v/v 0%
Butan-2-ol 10% v/v 20%
DMSO 10% v/v 102%
Dithioerithritol 1 mM 180%
2-Mercaptoethanol 1 mM 142%
GSH 1 mM 138%
GSSG 1 mM 32%
Two micrograms of ICMP, dissolved in bu¡er A with 0.1% Tri-
ton X-100 corresponds to 100% activity. Values are averages of
determinations in at least triplicates. KIU, Kallikrein-inhibiting
units.
Table 2
Puri¢cation of the ICMP from P. aeruginosa
Puri¢cation step Total protein
(mg)
Total activity
(Wg h31)
Speci¢c activity
(Wg mg31 h31)
Yield (%) Puri¢cation
factor
Washed cell envelopes 531 40.5 0.076 100 1
Solubilizate 169.2 108.3 0.64 267.4 8.4
Pool after IMAC 57.8 19.1 0.33 47.1 4.3
Pool after concentration and dialysis 48.8 23.9 0.49 59.0 6.4
Pool after I. Red-Sepharose 1.9 26.4 13.9 65.2 182.9
Pool after II. Red-Sepharose 0.4 25.2 63 62.2 828.9
Pool after concentration and dialysis 0.4 23.6 59 58.3 776.3
Results are averages of three di¡erent puri¢cation procedures.
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di¡erent conditions, while the proteinase was eluted
in the £ow-through fractions. The ICMP appeared
homogeneously in the SDS-PAGE after this puri¢ca-
tion procedure (Fig. 4) with a molecular mass of 50
kDa corresponding well to the results from size-ex-
clusion chromatography of 52 þ 2 kDa on Sephadex
G-150 (data not shown). Using MALDI-TOF-mass
spectrometry, a molecular mass of 44.6 þ 0.5 kDa
was determined after removing detergent and salts
by TCA precipitation. Di¡erences between the values
obtained by the di¡erent methods may be caused by
the speci¢c detergent binding of the membrane pro-
teinase, which is common for other membrane pro-
teins too [26].
3.4. Characterization
The puri¢ed enzyme had its pH-optimum in the
neutral range (6.0^7.0) and was highly unstable
against acid and alkaline pH (not shown). Only 60
min of incubation in bu¡ers below pH 6.0 and above
7.5 caused an irreversible inhibition of approximately
40% compared to the activity at pH 7.0. The temper-
ature optimum for the ICMP was between 37 and
40‡C. Its temperature stability at 40‡C was rather
low, only 30 min of incubation at 50‡C caused an
inactivation of 50% (data not shown).
The e¡ect of various protease inhibitors and site-
speci¢c reagents was tested by incubating the puri¢ed
protease for 30 min at room temperature prior to the
addition of 125I-labeled insulin (Table 1). Of the in-
hibitors tested, chelators were found to inhibit ICMP
activity strongly, implying that a central metal ion,
presumably zinc, is essential for activity (Table 1).
The chelator most e¡ective was EDTA, causing a
complete inhibition at a ¢nal concentration of 100
WM.
The proteinase, completely inhibited by o-phenan-
throline in the presence of 10 mM calcium ions as
recommended by Feder and Garret [27], could not be
reactivated again by the addition of various metal
ions. EDTA-inhibition and subsequent dialysis in
the presence or absence of calcium ions (1 mM) led
to a partial reactivation of the proteolytic activity
with zinc ions alone and to a complete reactivation
with an additional activating e¡ect, when calcium
ions were simultaneously present (Fig. 5). Calcium
ions alone reactivate the enzyme at a much higher
concentration range. The metal ion in the active cen-
ter was determined to be zinc (1 þ 0.02 mol Zn2 per
enzyme molecule) by HPLC coupled-online to ICP-
MS; no calcium ions bound to the enzyme protein
were detected [21].
Fig. 4. SDS-PAGE for the puri¢cation of the ICMP (10%
acrylamide). Lane 1, calibration proteins (ovalbumin 42.7 kDa,
glutamate dehydrogenase 56 kDa, ovotransferrin 78 kDa, phos-
phorylase b 97.4 kDa, L-galactosidase 116.3 kDa); lane 2, solu-
bilizate; lane 3, pool after IMAC and dialysis ; lane 4, pool
after I. Red-Sepharose CL-4B, lane 5, puri¢ed enzyme after II.
Red-Sepharose CL-4B, 5 min heated at 100‡C with 1% w/v
SDS, but without mercaptoethanol; lane 6, puri¢ed enzyme
heated with 5% mercaptoethanol; lane 7, same calibration pro-
teins as in lane 1.
Fig. 5. Reactivation of the ICMP by Zn2 and Ca2 ions after
EDTA inhibition and dialysis against bu¡er A without or with
1 mM CaCl2.
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Fig. 6. Cleavage speci¢city of ICMP from P. aeruginosa in comparison to elastase and alkaline protease.
Table 3
Cleavage of synthetic substrates by the puri¢ed ICMP (5 Wg puri¢ed enzyme per assay)
Substrate Relative activity (%)
Aminopeptidase substrates
L-Glu-pNA (aminopeptidase A) ^
L-Lys-pNA (aminopeptidase N) ^
L-Ala-pNA (aminopeptidase N) ^
L-Pro-pNA (prolyl aminopeptidase) ^
Dipeptidase substrates
Ala-Pro-pNA ^
Pro-Ala-pNA ^
Carboxypeptidase substrates
Bz-Gly-Lys ^
Bz-Gly-Phe ^
Proteinase substrates
Suc-Phe-pNA (chymotrypsin) ^
Suc-Gly-Phe-pNA (chymotrypsin) ^
Bz-Arg-pNA (trypsin) ^
Boc-Leu-Gly-Arg-s-pNA (complement convertase, factor Xa, plasminogen activator) 100%
Z-Phe-Arg-s-pNA (kallikrein) 75.8%
Bz-Phe-Val-Arg-s-pNA (thrombin) 30.9%
Tosyl-Gly-Pro-Lys-s-pNA (plasmin) 25.3%
Suc-Ala-Pro-Ala-pNA (elastase) ^
Glp-Phe-Leu-pNA (papain) ^
Suc-Ala-Ala-Val-pNA+AP-M (elastase) ^
Suc-Ala3-pNA (subtilisin) ^
Z-Gly-Gly-Leu-pNA (subtilisin) ^
+AP-M (neutral endopeptidase, elastase) ^
FAGLA (thermolysin, elastase) ^
FALGPA (collagenase) ^
Elastase substrate
Orcein elastin ^
Values are the averages of quadruple determinations. All substrates with more than one amino acid residue were tested without and
with aminopeptidase M.
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ICMP was not or only weakly inhibited by the
typical inhibitors (phosphoramidon, zincov, capto-
pril and thiorphan) of the thermolysin-like proteinase
family (family M4), from which the elastase of P.
aeruginosa is also a member [28] (Table 1). There-
fore, it can be assumed that the ICMP is not a mem-
ber of this metalloprotease family and is also not
identical to any membrane-bound proform of the
elastase from P. aeruginosa. This was con¢rmed us-
ing immunological methods (Fig. 9). The ICMP con-
tains histidine residues in its active center similar to
other zinc metalloproteases which was veri¢ed by
DEPC inhibition and its subsequent reactivation by
hydroxylamine [29] (Table 1).
Among the cysteine protease inhibitors tested, only
pCMB partially inhibited the puri¢ed enzyme. Pre-
sumably, the cysteine residues of the proteinase are
only peripheric and not located in the active center.
The kinetic parameters for insulin cleavage were
determined using various concentrations of cold por-
Table 4
Degradation of various radioactively labeled proteins by the pu-
ri¢ed ICMP from P. aeruginosa
Substrate protein Relative cleavage (%)
14C-casein 9.5
14C-ovalbumin 0.001
14C-globin 0.001
14C-bacteriorhodopsin 0.002
3H-elastin 5.4
125I-insulin 100
Two micrograms of puri¢ed enzyme and 3 Wg substrate protein
were used per assay, results are averages of quadruple determi-
nation.
Fig. 7. Cleavage of K- and L-casein by the ICMP from P. aeru-
ginosa (enzyme: substrate relation on weight basis 1:20, acryl-
amide concentration 15%) (from left to right: calibration pro-
teins Merck VIII; blank value for K-casein; blank value for L-
casein; blank for puri¢ed enzyme; main value for K-casein 1 h
incubation; main value for K-casein 2 h incubation; main value
for L-casein 1 h incubation; and main value for L-casein 2 h in-
cubation).
Fig. 8. Cleavage of human ¢brinogen by the ICMP from P.
aeruginosa (enzyme: substrate relation on weight basis 1:20,
acrylamide concentration 7.5%). (A) Under non-reducing condi-
tions (from right to left : calibration proteins Merck VIII; blank
value for the puri¢ed ICMP; blank value for ¢brinogen; main
value 2 h incubation; and main value 4 h incubation). (B)
Under reducing conditions (from right to left : calibration pro-
teins Merck VIII; blank value for ¢brinogen; blank value for
the puri¢ed ICMP; main value 2 h incubation; and main value
4 h incubation).
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cine insulin with an equally high label of 125I-insulin
and were calculated with the kinetic program enz-
pack3. For insulin cleavage by the ICMP, a Km value
of 120 þ 4 nM and a Vmax value of 0.76 þ 0.7 nM l31
s31 (mg enzyme protein)31 were determined. Various
polypeptides were tested for their capability to inhib-
it the insulin degradation (data not shown). Gluca-
gon was the most e¡ective competitive inhibitor
among the polypeptides tested; oxidized insulin A-
chain were not inhibitory at all. Insulin seems to be
the polypeptide substrate best accepted, because glu-
cagon had an inhibitory e¡ect beginning at a concen-
tration range of 10 WM (a 100-fold excess over the
insulin concentration in the assay adjusted to 100
nM with cold insulin).
To determine the time course for hydrolysis of
oxidized insulin A- and B-chain, the puri¢ed protease
was incubated with these substrates for varying peri-
ods and the reaction products were separated by re-
versed-phase HPLC. Only the insulin B-chain was
hydrolyzed substantially. The insulin A-chain was
not cleaved at all ^ a con¢rmation of the results
from the competitive inhibition experiments. The pri-
mary cleavage sites were identi¢ed to be Glu13-s-
Ala14 and Tyr16-s-Leu17 bonds. The secondary
cleavage sites were Phe25-s-Tyr26 and His10-s-
Leu11, determined from the masses of the corre-
sponding peptide pairs (Fig. 6).
The ICMP prefers the cleavage of hydrophobic
amino acids in the PP1-position, whereas variable res-
idues from bulky aromatic to ionic (Glu) ones are
accepted in the P1-position. Only four cleavage sites
were detected in the oxidized insulin B-chain, corre-
sponding to some of the cleavage sites from other
neutral metalloproteases [30], but with a much nar-
rower speci¢city than the alkaline protease or the
elastase. This is presumably a result of higher de-
mands on the steric conformation of the polypeptide
chain similar to the IDE, which prefers cleavage of
Tyr and Leu residues in K-helical regions [31]. These
results support our explanation that the ICMP can-
not bind to the insulin and bacitracin a⁄nity matri-
ces tested, because of high steric demands.
Fig. 9. Immunodouble di¡usion for the pure elastase and the
puri¢ed ICMP from P. aeruginosa with antiserum against elas-
tase. 1. Circle: center, 10 Wl elastase (0.1 mg ml31, 1:2 diluted).
2. Circle: center, 10 Wl puri¢ed ICMP (0.05 mg ml31) ; outer
sectors, 5 Wl elastase rabbit antiserum each beginning with the
upper position: 1, undiluted; 2, 1:2 diluted; 3, 1:4 diluted; 4,
1:8 diluted; 5, 1:16 diluted. Precipitation lines were found only
in the ¢rst circle, ICMP did not react with elastase antiserum.
Table 5
Typical properties of the ICMP in comparison to the elastase and the alkaline protease from P. aeruginosa
ICMP Elastase Alkaline protease
Molecular mass 44.6 kDa 33 kDa [55] 46.4 kDa [44]
Expression logarithmic phase stationary phase [55] stationary phase [55]
pI 5.3 5.9 [55] 4.1 [55]
0.5 M NaCl 45% r.a. 100% [56] 100% [55]
pH stability pH 5 = 38% r.a. stable stable
pH 10 = 12% r.a. stable stable
Temperature stability up to 40‡C up to 50‡C [55] up to 60‡C [55]
elastolytic activity (+) + [56] 3 [55]
Z-Phe-Arg-pNA (+) 3 + [46]
FAGLA 3 + [24] 3
pCMB (1 mM) 63% r.a. 100% r.a. [56] 100% r.a. [55]
EDTA (1 mM) 1 mM 0% r.a. 5% r.a. [56] 70% r.a. [55]
o-Phenanthroline 1 mM 6% r.a. 10% r.a. [56] 20% r.a. [55]
Phosphoramidon 0.1 mM = 73% r.a. Ki = 32 nM [46] 3 [42]
Zincov Ki = 70 WM Ki = 57 nM [46] 3 [42]
r.a., residual activity.
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Neither synthetic aminopeptidase and carboxypep-
tidase substrates tested nor substrates of thermolysin
and pseudolysin were cleaved (Table 3). Only p-ni-
troanilide substrates with at least two amino acid
residues were cleaved at a low rate at the bond ad-
jacent to the nitroanilide residue, when arginine was
located in the P1-position. Substrates cleaved by
ICMP are typical substrates of proteases from the
blood coagulation system (thrombin, factor Xa),
the complement system (complement convertase 5)
and of the plasminogen activator and plasmin (Table
3) [32^34]. The relative cleavage rate of various sub-
strates was determined, but even the cleavage rate for
the best substrate (Boc-Leu-Gly-Arg-pNA) was very
low.
The cleavage of various radioactive labeled pro-
teins by the ICMP was investigated (Table 4) and
the results obtained were veri¢ed by SDS-PAGE.
Most of the substrate proteins tested were not
cleaved, with the exception of K- and L-casein (Fig.
7). 125I-insulin was degraded at an essentially higher
rate than 14C-labeled casein (Table 4). A cleavage of
orcein-elastin could not be detected. The elastolytic
capability of the ICMP could be ¢rst established by a
more sensitive assay with 3H-labeled elastin. Most
other proteins tested were not degraded (acid soluble
collagen type I, ¢bronectin, laminin, immunoglobulin
A, immunoglobulin G, human serum albumin, K1-
antitrypsin).
Fibrinogen was cleaved in a speci¢c manner under
non-reducing conditions, not resulting in a broad
variety of cleavage peptides, but in a de¢ned ¢brin(o-
gen) track with a slight shift in mobility compared to
¢brinogen itself (Fig. 8A). After the reduction of
¢brinogen, it became visible that only the ¢brinogen
K- and L-chains were degraded, the Q-chain remained
intact (Fig. 8B).
Polyclonal antibodies against pure elastase of P.
aeruginosa were generated in rabbits. Elastase-antise-
rum reacted with only one uniform track in Western
blot after reaction with anti-rabbit-IgG (POD-la-
beled). For the determination of the immunological
similarity between elastase of P. aeruginosa and the
puri¢ed ICMP, the method of immunodouble di¡u-
sion was applied (Fig. 9). The puri¢ed membrane
proteinase showed no immunological relationship
to the elastase.
Since the N-terminus of the ICMP is blocked,
some internal peptide sequences were determined as
follows:
Peptide 1:
-Met1-Phe2-Phe3-Gly4-Met5-Gly6-Ser7-Leu8-Ser9-
Leu10-Gly11-Cys12-Leu13-Ala14-Gly15-(Glu16-Arg17)-
Peptide 2:
-Ala1-Val2-Thr3-Asp4-Leu5-Leu6-Val7-Ser8-Asp9-
Leu10-Glu11-Tyr12-Met13-Ala14-Gly15-Gln16-Gly17-
(Tyr18-His19-Ala20-Ile21)-
No high-homologous sequences were found in the
result of the investigations in protein sequence data
banks using the BLAST P algorithm. In accordance
with the results obtained for the substrate and inhib-
itor speci¢city of the membrane proteinase from P.
aeruginosa, it is a novel protein unlike the known
extra- and intracellular proteinases from Pseudomo-
nas strains.
4. Discussion
The ICMP can be regarded as a membrane pro-
teinase, located at the outer side of the bacterial cell,
showing the typical amphiphilic properties of a mem-
brane protein. If proteins were found attached to the
cell-envelope of Gram-negative bacteria, then such
proteins could be contaminations originating from
medium, periplasm or cytosol bound loosely by ionic
or hydrophobic interactions. Using wash procedures,
such proteins are removable as has been well de-
scribed [35,36]. The ICMP remained bound to the
outer membrane fraction in sucrose density gradients
(Fig. 2) in spite of the wash steps and nuclease and
lysozyme treatment ^ therefore, cell wall binding can
be excluded. The protease was solubilizable only by
high concentrations of non-ionic detergent. The main
part of the solubilized proteolytic activity was en-
riched in the detergent phase as result of phase par-
tition experiments [10], a typical behavior for integral
membrane proteins with at least one hydrophobic
part in the molecule [37].
Because extracellular proteases traverse the cell en-
velope following di¡erent mechanisms, binding of
proforms or of the mature protease itself to the en-
velope cannot be excluded. The secretion and matu-
ration of the elastase has been intensively investi-
gated. The elastase is synthesized as preproprotein
with a molecular weight of 53.6 [38] containing a
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long N-terminal propeptide, which is processed to
mature form via a 51-kDa proelastase. The proelas-
tase remain inactive because of interaction with the
propeptide which functions as a protease inhibitor
and as a chaperone for the correct folding of the
proelastase to the mature enzyme [39]. Proforms of
secreted proteases activate themselves; therefore,
they must possess at least low proteolytic activity
[38,39]. That was the reason for comparing the prop-
erties of the isolated ICMP with elastase in regard to
its immunological (Fig. 9) and enzymological proper-
ties (Table 5).
Elastase (pseudolysin, EC 3.4.24.26) cleaves tetra-
peptides as tetraalanine or Fa-tripeptides, like FA-
GLA (Tables 3 and 5). Contrary to the ICMP, typ-
ical cleavage sites of the elastase in the insulin B-
chain and in synthetic peptide substrates are Ala-
s-Leu and Gly-s-Phe (Table 3) [30,40]. The sub-
strates Suc-Ala-Ala-s-Val-pNA and Z-Gly-Gly-s-
Leu-pNA (Table 3) are cleaved by elastase and neu-
tral endopeptidase (EC 3.4.24.11) [41] in an internal
position, detectable only by the combined assay with
aminopeptidase M. Thermolysin-like proteases prefer
binding of substrates and inhibitors with a hydro-
phobic residue in the PP1 position and an aromatic
residue in the PP2 position [42]. Phosphoramidon,
one of best acting inhibitors of thermolysin, neutral
endopeptidase and elastase (Ki 32 nM) [43], caused in
a concentration of 0.1 mM only a weak inhibition of
the ICMP. The Ki-value of zincov, another speci¢c
inhibitor for thermolysin-like metalloproteases, was
more than 1000-fold higher for ICMP than for elas-
tase (Table 5) [43].
The alkaline protease gene encodes for a 46.4-kDa
protein and does not contain any signal peptide and
propeptide sequences [44]. A secretion way, like
those of the extracellular proteases of Erwinia chry-
santhemi and K-hemolysin of Escherichia coli, over
the adhesion zones between the outer and the cyto-
plasmic membrane was postulated [44], therefore, cell
envelope-bound proforms are unlikely, but mature
alkaline protease can be loosely attached to the cell
envelope.
The ICMP is di¡erent in its properties from this
enzyme too. The pH-optimum of the ICMP is in
di¡erence to the alkaline protease in the neutral
range. The alkaline protease was not inhibited by
zincov and phosphoramidon [45] and its cleavage
speci¢city for insulin B-chain [30,46] is diverse (Table
3). Synthetic substrates of kallikrein (Z-Phe-Arg-
pNA), plasmin and thrombin are cleaved by both
proteases, but with another speci¢city in the P2-posi-
tion. While the alkaline protease prefers Phe and
other bulky hydrophobic residues in this position
[46], the ICMP cleaves preferentially the substrate
(Bz-Leu-Gly-Arg-pNA), a substrate of complement
convertase, plasminogen activator and of blood clot-
ting factor Xa [47], which is a poor substrate for the
alkaline protease [46]. This substrate was cleaved
with the highest rate in relation to other synthetic
substrates tested (Table 3), but the velocity is too
low (w1.4U10310 mol s31 mg31 puri¢ed enzyme)
to determine kinetic parameters. The cleavage specif-
icity for the insulin B-chain will be the basis for
further investigations into the substrate speci¢city.
Besides these two extracellular metalloproteases, a
second elastolytic protease, called LasA, is expressed
late in the growth as a 41-kDa precursor protein,
which is secreted as an active 22-kDa fragment into
the medium [48]. This enzyme belongs to the family
of the L-lytic endopeptidases with a preferential
cleavage speci¢city for Gly-Ala bonds internally lo-
cated in the Gly-Gly-Ala sequences of the peptido-
glycan layer of Gram-positive bacteria resulting in
the capability for staphylolysis [48]. Outer mem-
brane-bound proform of LasA could principally be
identical with the ICMP too, but LasA is not inhib-
itable by o-phenanthroline and only slightly by
EDTA. It can only degrade elastin, but not any other
substrate protein. pH-optimum and pI of LasA are
in the alkaline range (pI 9.25) [48]. These divergent
properties are convincing arguments against ICMP
as a proform of LasA.
All results prove that the ICMP of P. aeruginosa
and these secreted proteases are di¡erent enzymes.
To demonstrate that the ICMP is a protein with
an unknown sequence, internal peptides from the
trypsin digestion of the puri¢ed ICMP were se-
quenced. No homologies in the amino acid sequence
were found with any of the described extracellular
proteases from P. aeruginosa and with other known
bacterial outer membrane proteases.
The ICMP from P. aeruginosa cleaves preferen-
tially polypeptides and only few radioactive-labeled
proteins with a lower rate in comparison to insulin.
Surprisingly, the pure ICMP degrades K- and L-ca-
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seins in contrast to other insulin-degrading proteases,
like protease III from E. coli [49] and IDE [50], a
contradiction to the hypothesis of a so-called ‘size-
recognition’ by oligo- and polypeptide-cleaving pro-
teases [49,50].
Fibrinogen was also degraded, but highly speci¢c,
generating a de¢ned large protein in the SDS-electro-
phoresis under non-reducing conditions (Fig. 8A),
because only the K- and L-chains were cleaved (Fig.
8B) similar to thrombin action [51]. This de¢ned
cleavage of ¢brinogen by the ICMP together with
its substrate speci¢city similar to factors of blood-
clotting, ¢brinolyze and complement systems support
the assumption that the ICMP could play a role in
the pathogenicity of P. aeruginosa. The ICMP was
formed early in the growth in contrast to the extra-
cellular proteases and can support the supply of the
bacterial cell with peptides by the cleavage of poly-
peptides and some proteins at the beginning of
growth and colonization. A bacterial surface protein-
ase with a speci¢c action on the blood-clotting,
¢brinolyze and complement system would be a very
important enzyme for the pathogenicity, because this
happens in the logarithmic growth phase, when ex-
tracellular proteinases are not yet secreted. Similar
outer membrane proteases interacting with the host
defense system, but belonging to the serine protease
type, are described for Yersinia pestis [9,52], Esche-
richia coli [52,53] and Salmonella typhimurium [53,
54].
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